Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices

ASAIO Journal

Volumn 61, Issue 1, 2015, Pages 107-109

  Loyaga Rendon, Renzo Y ^a   Hashim, Taimoor ^a   Tallaj, Jose A ^a   Acharya, Deepak ^a   Holman, William ^b   Kirklin, James ^b   Pamboukian, Salpy V ^a  

^a University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

gastrointestinal bleed; LVAD; octreotide

Indexed keywords

BLOOD; ENDOSCOPY;

BLOOD TRANSFUSION; CONTINUOUS FLOWS; GASTROINTESTINAL; OCTREOTIDE; PROSPECTIVE STUDY; RED BLOOD CELL;

LEFT VENTRICULAR ASSIST DEVICES;

OCTREOTIDE; GASTROINTESTINAL AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; OFF LABEL DRUG USE; PRIORITY JOURNAL; RECURRENT DISEASE; ADVERSE EFFECTS; AGED; COHORT ANALYSIS; HEART ASSIST DEVICE;

AGED; COHORT STUDIES; ENDOSCOPY, GASTROINTESTINAL; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HEART-ASSIST DEVICES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; OFF-LABEL USE; RECURRENCE;

EID: 84929046742     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000143     Document Type: Article

References (20)

1. Forest SJ, Bello R, Friedmann P, et al. Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital. Ann Thorac Surg 95: 1276-1281, 2013
2. Brown C, Subramanian V, Wilcox CM, Peter S. Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: An overview and systematic review of prospective observational studies. Dig Dis Sci 55: 2129-2134, 2010
3. Heyde EC. Gastrointestinal bleeding in aortic stenosis. N Engl J Med. 259: 196, 1958
4. Wever-Pinzon O, Selzman CH, Drakos SG, et al. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail 6: 517-526, 2013
5. Sami SS, Al-Araji SA, Ragunath K. Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management. Aliment Pharmacol Ther 39: 15-34, 2014
6. Junquera F, Saperas E, de Torres I, Vidal MT, Malagelada JR. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol 94: 1070-1076, 1999
7. Fujita H, Momoi M, Chuganji Y, Tomiyama J. Increased plasma vascular endothelial growth factor levels in patients with angiodysplasia. J Intern Med 248: 268-269, 2000
8. Meyer AL, Malehsa D, Bara C, et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 3: 675-681, 2010
9. Starke RD, Ferraro F, Paschalaki KE, et al. Endothelial von Willebrand factor regulates angiogenesis. Blood 117: 1071-1080, 2011
10. Feldman D, Pamboukian SV, Teuteberg JJ, et al. International Society for Heart and Lung Transplantation: The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary. J Heart Lung Transplant 32: 157-187, 2013
11. Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant 33: 12-22, 2014
12. Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 370: 33-40, 2014
13. Junquera F, Santos J, Saperas E, Armengol JR, Malagelada JR. Estrogen and progestagen treatment in digestive hemorrhage caused by vascular malformations. Gastroenterol Hepatol 18: 61-65, 1995
14. Ge ZZ, Chen HM, Gao YJ, et al. Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Gastroenterology 141: 1629-1637.e1, 2011
15. Reichlin S. Somatostatin. N Engl J Med ;309:1495-1501, 1983
16. Lamberts SW, van Der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 334: 246-254, 1996
17. Kurosaki M, Saegert W, Abe T, Lüdecke DK. Expression of vascular endothelial growth factor in growth hormone-secreting pituitary adenomas: Special reference to the octreotide treatment. Neurol Res 30: 518-522, 2008
18. Rennyson SL, Shah KB, Tang DG, et al. Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?. ASAIO J 59: 450-451, 2013
19. Hayes HM, Dembo LG, Larbalestier R, O'Driscoll G. Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: A single-center experience. Artif Organs 34: 703-706, 2010
20. Aggarwal A, Pant R, Kumar S, et al. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg 93: 1534-1540, 2012